Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

18 results about "Levamlodipine" patented technology

Levamlodipine (INN), also known as levoamlodipine or S-amlodipine is a pharmacologically active enantiomer of amlodipine. Amlodipine belongs to the dihydropyridine group of calcium channel blocker used as an antihypertensive and antianginal agent. Levamlodipine is currently marketed in Russia under the brand name EsCordi Cor (Actavis Pharma), in Brazil under the brand name Novanlo (Biolab Sanus) and in India under the trade names Eslo (Zuventus Healthcare Ltd.), Asomex (Emcure Pharmaceutical Ltd.), and Espin (Intas Pharmaceuticals Ltd.).

Low-moisture levamlodipine besylate composition and preparation method thereof

The invention belongs to the field of medicine preparation, and relates to a low-moisture levamlodipine besylate composition and a preparation method thereof, and the composition comprises the following components: 2-10 wt% of levamlodipine besylate or its hydrate; the content of anhydrous calcium hydrogen phosphate is 10-30 wt%; the content of microcrystalline cellulose is 30-80 wt%; 1-5wt% of a disintegrating agent; and the content of the lubricant is 0.1-5 wt%. According to the method disclosed by the invention, the stability of the levamlodipine besylate preparation under high-temperature and high-humidity conditions is remarkably improved by optimizing and adjusting the drying step.
Owner:江苏济茗医药有限公司

Oral solid medicinal composition containing irbesartan and preparation method thereof

The invention belongs to the technical field of pharmaceutical preparations, and relates to an oral solid pharmaceutical composition containing irbesartan and a preparation method thereof. Irbesartan particles are prepared by adopting a wet granulation process, levamlodipine besylate particles are prepared by adopting a dry granulation process, the irbesartan particles and the levamlodipine besylate particles are mixed, a filling agent adopted in the dry granulation process is microcrystalline cellulose, and the mass ratio of irbesartan to levamlodipine besylate is (150-300): (2-4). The content uniformity of the levamlodipine besylate can meet the standard, and the stability of the composition can be improved.
Owner:JIANGXI SHIMEI PHARM CO LTD

Detection method of levamlodipine besylate tablet related substances

The invention belongs to the field of medicine detection, and relates to a detection method of levoamlodipine besylate tablet related substances, which comprises the following steps: quantitatively detecting the levoamlodipine besylate tablet related substances by high performance liquid chromatography; high performance liquid chromatography conditions are as follows: a chromatographic column uses octadecylsilane chemically bonded silica as a filler; a mobile phase A is a 0.7% triethylamine solution; a mobile phase B is methanol-acetonitrile (70: 30); the flow rate is 1.0 ml / min; the column temperature is 25 DEG C; the detection wavelength is 237 nm; and the diluent is obtained by uniformly mixing 200ml of the mobile phase A and 800ml of the mobile phase B. According to the chromatographic conditions provided by the invention, the separation degree between the impurities and the main peak is good, the peak pattern is good, the baseline fluctuation is smooth, and the peak pattern and the separation degree of the impurities are both improved compared with those of the primary chromatographic conditions.
Owner:江苏济茗医药有限公司

Method for detecting N-nitroso benazepril impurity in levamlodipine benazepril

PendingCN119335095AComponent separationNitrosoLevamlodipine
The invention discloses a method for detecting N-nitroso benazepril impurities in levamlodipine benazepril, which comprises the following steps: grinding a benazepril hydrochloride tablet to be detected, mixing and dissolving the benazepril hydrochloride tablet with 1-methyl-2-pyrrolidone and a solvent according to the mass ratio of the effective amount of benazepril hydrochloride to the mass of 1-methyl-2-pyrrolidone of (10-50): 1, filtering, and concentrating to obtain the N-nitroso benazepril impurities in levamlodipine benazepril. Obtaining a test solution; and detecting the impurities of the N-nitroso benazepril in the test solution by adopting liquid chromatography-tandem mass spectrometry. The detection method provided by the invention is a liquid chromatography-mass spectrometry method, has the characteristics of strong specificity, high sensitivity, high accuracy and the like, and is suitable for trace detection of N-nitroso benazepril in the levamlodipine benazepril capsule preparation.
Owner:SHANDONG CHUANGXIN PHARMA RES & DEV

Levoamlodipine besylate tablet crusher

The utility model discloses a levamlodipine besylate tablet crusher, and particularly relates to the technical field of tablet processing, the levamlodipine besylate tablet crusher comprises a crushing cavity, the top of the crushing cavity is provided with a sealing cover in a threaded manner, the bottom of the crushing cavity is provided with a charging box in a threaded manner, the sealing cover is fixedly provided with a crushing motor, and the output end of the crushing motor is fixedly provided with a rotating shaft; a first smashing cutter and a second smashing cutter are arranged at the bottom of the rotating shaft, the second smashing cutter is located at the bottom of the first smashing cutter, a dust absorption structure is arranged on the surface of the sealing cover and located on one side of the smashing motor, the dust absorption structure comprises a treatment box, and the treatment box is located on one side of the smashing cavity. According to the levamlodipine besylate tablet crushing device, levamlodipine besylate tablets can be well crushed, generated dust can be absorbed and filtered in the crushing process, the situation that dust escapes in the environment and affects operators is avoided, and the whole levamlodipine besylate tablet crushing device is convenient to disassemble, assemble and maintain.
Owner:CHANGZHOU RUIMING PHARMACEUTICAL COMPANY LTD

Perindopril-levamlodipine compound tablet and preparation method thereof

The invention belongs to the technical field of pharmaceutical preparations, and relates to a perindopril-levamlodipine compound tablet and a preparation method thereof. The filling agent in the auxiliary materials is sieved, the sieved filling agent is divided into three parts, and the auxiliary materials do not contain lactose; mixing the perindopril arginine, docusate sodium in the auxiliary materials and the first part of filler to obtain a first premix; mixing levamlodipine besylate and a second part of filler to obtain a second premix; and uniformly mixing the first premix, the second premix and the remaining auxiliary materials, and tabletting to obtain the tablet. According to the preparation method provided by the invention, the mixing uniformity can be remarkably improved, the product quality consistency can be improved, and meanwhile, the bioavailability and the stability of the two main drugs can be improved.
Owner:JIANGXI SHIMEI PHARM CO LTD

Synthesis reactor for levamlodipine besylate

The utility model discloses a synthesis reactor for levamlodipine besylate, which relates to the technical field of medical equipment, and comprises a tank body, a mounting shaft is rotatably connected in the tank body, a plurality of groups of stirring arms are fixedly connected on the outer side of the mounting shaft, and a first mounting ring and a second mounting ring are fixedly connected in the tank body. The first mounting ring is arranged above the second mounting ring, a scraping rod is arranged in the tank body, the upper end and the lower end of the scraping rod are slidably connected to the interiors of the first mounting ring and the second mounting ring correspondingly, the side face of the scraping rod is attached to the inner wall of the tank body, and a driving assembly is arranged at the top of the scraping rod; the driving assembly drives the scraping rod to do circular motion between the first installation ring and the second installation ring, in the moving process of the scraping rod, the outer side face of the scraping rod acts on the inner wall of the tank body, residues on the inner wall of the tank body are scraped away, and equipment cleaning is more convenient.
Owner:HEFEI GUOGAO PHARM CO LTD

Levoamlodipine folic acid compound tablet and preparation method thereof

The invention belongs to the technical field of pharmaceutical preparations, and relates to a levoamlodipine folic acid compound tablet and a preparation process thereof, and the preparation process comprises the following steps: mixing microcrystalline cellulose with vitamin C, and enabling nitrite in the microcrystalline cellulose to be in full contact with the vitamin C to obtain a first mixture; mixing folic acid with part of the first mixture to obtain a second mixture; mixing levamlodipine besylate with the remaining first mixture to obtain a third mixture; and uniformly mixing the second mixture, the third mixture and other auxiliary materials, and tabletting to obtain the tablet. The method comprises the following steps: reacting microcrystalline cellulose with vitamin C to consume nitrite in the microcrystalline cellulose so as to prevent the nitrite from reacting with secondary amino in levamlodipine to generate nitrosamine impurities with genetic toxicity;
Owner:SHANDONG CHUANGXIN PHARMA RES & DEV

Bisoprolol amlodipine tablet

The invention belongs to the technical field of pharmaceutical preparations, and particularly relates to bisoprolol amlodipine tablets and a preparation method thereof. The bisoprolol amlodipine tablet is composed of a bisoprolol fumarate solid dispersion, amlodipine besylate / levamlodipine besylate, a filler, a disintegrating agent and a lubricant, the bisoprolol fumarate solid dispersion takes HPMCP as a carrier material, and triethyl citrate is added. The obtained bisoprolol and amlodipine tablet blocks the contact opportunity of bisoprolol fumarate and amlodipine, the problem of compatibility of bisoprolol fumarate and amlodipine is fundamentally solved, the storage requirement can be met without special packaging, the preparation process is simple, and the industrialization requirement is met.
Owner:SHANDONG NEW TIME PHARMA CO LTD

A valsartan levoamlodipine tablet composition, valsartan levoamlodipine tablet and its preparation process and application

The present invention provides a valsartan levamlodipine tablet composition, a valsartan levamlodipine tablet and a preparation process and application thereof, and belongs to the technical field of pharmaceutical preparations. The valsartan levamlodipine tablet composition is composed of a valsartan composition and a levamlodipine besylate composition; the valsartan composition is composed of valsartan, a filler, a disintegrant, a glidant and a lubricant; the levamlodipine besylate composition is composed of levamlodipine besylate, sodium carboxymethyl starch and a lubricant; the particle size d90 of the valsartan is 10-100 μm, and the particle size d90 of the levamlodipine besylate is 20-90 μm; in the levamlodipine besylate composition, the mass ratio of the levamlodipine besylate to the sodium carboxymethyl starch is 7:9-14. The tablet successfully improves the release effect of levamlodipine in the valsartan-levamlodipine combined preparation.
Owner:HANGZHOU MUYUAN BIOMEDICAL TECHNOLOGY CO LTD +1

Determination method for irbesartan and levoamlodipine compound tablet related substances

PendingCN120522320AComponent separationO-Phosphoric AcidLevamlodipine
The invention belongs to the technical field of pharmaceutical analysis, and particularly relates to a method for determining related substances of irbesartan and levoamlodipine compound tablets. According to the method, high performance liquid chromatography is adopted for detection, a chromatographic column is YMC-Triart C18, a 0.55% phosphoric acid aqueous solution with the pH value of 3.0-3.5 is used as a mobile phase A, methanol is used as a mobile phase B, and gradient elution is performed. According to the method, known impurities and various unknown impurities including amlodipine impurities A, B, D, E, F, G and H, irbesartan impurities I and the like can be measured under the same chromatographic condition, the separation degree of each chromatographic peak and a main peak or other impurity peaks meets the requirements, the peak shape is good, the method is high in specificity, good in reproducibility and high in accuracy, the sensitivity meets the analysis and detection requirements, and the method is suitable for industrial production. And a reliable detection method is provided for related substances of the irbesartan-levoamlodipine compound.
Owner:成都硕德药业有限公司

Tablet containing arginine perindopril and levamlodipine besylate and preparation method thereof

According to the tablet containing the arginine perindopril and the levamlodipine besylate and the preparation method of the tablet, the pregelatinized starch and microcrystalline cellulose colloidal silicon dioxide co-treated substance is used as a filling agent, and the proportion of the pregelatinized starch and the microcrystalline cellulose colloidal silicon dioxide co-treated substance is controlled, so that the tablet containing the arginine perindopril and the levamlodipine besylate is prepared. The problem that the fluidity of the tablet is poor in preparation is solved, the stability is remarkably improved, the tablet has the advantages of being simple in preparation method, low in cost, good in fluidity, good in compressibility and the like, meanwhile, the tablet shows rapid disintegration, dissolution and stability, and the tablet is suitable for large-scale industrial production.
Owner:NANJING HEALTHNICE PHARMACEUTICAL CO LTD +3

Composition containing levamlodipine besylate hydrate and its preparation method

The present invention relates to a composition comprising levamlodipine besylate hydrate and its production, pharmaceutical preparations and use, especially the composition of (S)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylic acid-3-ethyl ester, 5-methyl ester benzenesulfonic acid hydrate and its production method and use. The composition of levamlodipine besylate crystallized in pure water and dried is easy for industrial production, has no organic solvent residue, good thermal stability and good dissolution amount in solid-form preparations.
Owner:SHIHUIDA PHARMACEUTICALS GROUP (JILIN) LTD +1

Method for chiral separation and determination of levamlodipine in human plasma by LC-MS / MS (Liquid Chromatography-Mass Spectrometry / Mass Spectrometry) method

The invention provides a method for measuring levamlodipine in human plasma through LC-MS / MS (liquid chromatography-mass spectrometry / mass spectrometry) chiral separation, which comprises the following steps: A, sample pretreatment: adding an internal standard working solution into to-be-measured plasma, then adding an extracting agent, carrying out vortex and centrifugation, then taking supernate, concentrating until the supernate is dry, and finally redissolving; b, preparing a standard curve and a quality control sample, namely preparing a levamlodipine standard curve sample and a quality control sample working solution, adding the working solution into blank plasma, uniformly mixing, and preparing the levamlodipine standard curve sample and the quality control sample with a series of concentration gradients. C, LC-MS / MS (liquid chromatography-tandem mass spectrometry) determination. According to the present invention, the chiral chromatographic column is adopted to perform the chromatographic separation of the enantiomer, and the LC-MS / MS detection method with characteristics of high specificity, strong specificity, rapid pretreatment, high efficiency, high reproducibility, strong operability, rapid analysis speed, low cost investment and wide application range is established.
Owner:TIANJIN HANYI PHARM TECH CO LTD +1

Pharmaceutical composition for treating cardiovascular diseases and preparation method thereof

The invention relates to a pharmaceutical composition for treating cardiovascular diseases and a preparation method thereof, in particular to a pharmaceutical composition containing levamlodipine besylate and atorvastatin calcium, and the pharmaceutical composition is used for treating mixed hypertension and hyperlipidemia, has a synergistic effect and can effectively reduce blood pressure and blood fat levels. By controlling the granularity and crystal form of levamlodipine besylate and atorvastatin calcium, the dissolution rate and stability of the medicine are optimized. The preparation method adopts a direct powder tabletting process, so that the production process is simplified, the production efficiency is improved, and meanwhile, the uniformity and the stability of the medicine are ensured. In-vitro dissolution experiments show that the dissolution rate of the composition reaches 90% or above within 15 minutes, and the composition has good bioavailability.
Owner:HONGYI SCI & TECH CO LTD NANCHANG

Levoamlodipine maleate crystal form and preparation method thereof

The invention belongs to the technical field of raw material crystal forms, and particularly relates to a L-amlodipine maleate crystal form and a preparation method thereof. Cu-K alpha radiation is used, and X-ray diffraction represented by a 2 theta angle (degree) has peaks at the following positions: 4.5 + / -0.2 degrees, 8.8 + / -0.2 degrees, 11.8 + / -0.2 degrees, 13.2 + / -0.2 degrees, 13.5 + / -0.2 degrees, 15.7 + / -0.2 degrees, 17.6 + / -0.2 degrees, 18.4 + / -0.2 degrees, 22.2 + / -0.2 degrees, 22.6 + / -0.2 degrees, 23.2 + / -0.2 degrees, 24.8 + / -0.2 degrees, 26.4 + / -0.2 degrees, 29.1 + / -0.2 degrees, 30.3 + / -0.2 degrees, 35.4 + / -0.2 degrees and The purity and the stability of the novel crystal form are better than those of an original product, the operation is simpler, the salt is directly formed, refining is not needed, the yield is higher, and the batch is not limited any more.
Owner:CHANGCHUN LANJIANG PHARM TECH CO LTD

Pharmaceutical composition for treating hypertension and preparation method thereof

The invention relates to a pharmaceutical composition for treating hypertension and a preparation method thereof, in particular to a pharmaceutical composition containing valsartan and levamlodipine besylate. The valsartan and the levamlodipine besylate are combined for use, so that the valsartan and the levamlodipine besylate not only can play a synergistic effect and enhance a treatment effect, but also have relatively high safety and relatively low adverse reaction occurrence rate, and are worthy of wide popularization and application. By controlling the crystal form of levamlodipine besylate and the particle sizes of valsartan, levamlodipine besylate, filler, disintegrating agent, lubricant and glidant and packaging with medicinal aluminum foil, polyvinyl chloride solid medicinal hard tablets and polyamide / aluminum cold-formed solid medicinal composite hard tablets, the dissolution rate and stability of the medicine are optimized. According to the method, direct powder tabletting is adopted, the powder fluidity is good, tabletting is easy, the production time is shortened, the production efficiency is improved, and the product stability is also improved. In-vitro dissolution experiments show that the dissolution curve of the composition is consistent with that of a control preparation, and the composition has good bioavailability.
Owner:HONGYI SCI & TECH CO LTD NANCHANG

Compound bisoprolol-levamlodipine tablet and preparation method thereof

The invention relates to the technical field of pharmaceutical preparation preparation processes, in particular to a compound bisoprolol and levamlodipine tablet and a preparation method thereof. According to the bisoprolol and bisoprolol fumarate bisoprolol double-layer tablet provided by the invention, the bisoprolol raw material is prepared into core particles by adopting wet granulation, and then the bisoprolol fumarate raw material is wrapped, so that the bisoprolol fumarate raw material is prevented from being in contact with the levamlodipine besylate raw material, and the growth speed of impurities formed by adding the bisoprolol and the bisoprolol fumarate into the impurities is obviously reduced. The levoamlodipine layer adopts a mode of dry granulation after mixing, the content of main drugs in the prepared granules is uniform, the layering risk in the tabletting process is reduced, and finally, the two layers of granules are pressed into double-layer tablets by adopting a double-layer tablet press, so that the contact of the two main drugs is avoided. The bisoprolol and levoamlodipine double-layer tablet provided by the invention has better stability, the levoamlodipine content uniformity is better, and the dissolution curve is closer to that of contrast drugs such as a bisoprolol fumarate tablet (Kinapi) and an amlodipine besylate tablet (Heishi).
Owner:SHANDONG CHUANGXIN PHARMA RES & DEV